259 related articles for article (PubMed ID: 33564793)
1. Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity.
Sindelar M; Stancliffe E; Schwaiger-Haber M; Anbukumar DS; Albrecht RA; Liu WC; Travis KA; García-Sastre A; Shriver LP; Patti GJ
medRxiv; 2021 Feb; ():. PubMed ID: 33564793
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.
Sindelar M; Stancliffe E; Schwaiger-Haber M; Anbukumar DS; Adkins-Travis K; Goss CW; O'Halloran JA; Mudd PA; Liu WC; Albrecht RA; García-Sastre A; Shriver LP; Patti GJ
Cell Rep Med; 2021 Aug; 2(8):100369. PubMed ID: 34308390
[TBL] [Abstract][Full Text] [Related]
3. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.
Roberts I; Wright Muelas M; Taylor JM; Davison AS; Xu Y; Grixti JM; Gotts N; Sorokin A; Goodacre R; Kell DB
Metabolomics; 2021 Dec; 18(1):6. PubMed ID: 34928464
[TBL] [Abstract][Full Text] [Related]
4. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
Ansone L; Briviba M; Silamikelis I; Terentjeva A; Perkons I; Birzniece L; Rovite V; Rozentale B; Viksna L; Kolesova O; Klavins K; Klovins J
Microbiol Spectr; 2021 Dec; 9(3):e0033821. PubMed ID: 34878333
[TBL] [Abstract][Full Text] [Related]
5. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study.
Byeon SK; Madugundu AK; Garapati K; Ramarajan MG; Saraswat M; Kumar-M P; Hughes T; Shah R; Patnaik MM; Chia N; Ashrafzadeh-Kian S; Yao JD; Pritt BS; Cattaneo R; Salama ME; Zenka RM; Kipp BR; Grebe SKG; Singh RJ; Sadighi Akha AA; Algeciras-Schimnich A; Dasari S; Olson JE; Walsh JR; Venkatakrishnan AJ; Jenkinson G; O'Horo JC; Badley AD; Pandey A
Lancet Digit Health; 2022 Sep; 4(9):e632-e645. PubMed ID: 35835712
[TBL] [Abstract][Full Text] [Related]
6. The Development and Validation of Simplified Machine Learning Algorithms to Predict Prognosis of Hospitalized Patients With COVID-19: Multicenter, Retrospective Study.
He F; Page JH; Weinberg KR; Mishra A
J Med Internet Res; 2022 Jan; 24(1):e31549. PubMed ID: 34951865
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation.
Ceballos FC; Virseda-Berdices A; Resino S; Ryan P; Martínez-González O; Peréz-García F; Martin-Vicente M; Brochado-Kith O; Blancas R; Bartolome-Sánchez S; Vidal-Alcántara EJ; Albóniga-Díez OE; Cuadros-González J; Blanca-López N; Martínez I; Martinez-Acitores IR; Barbas C; Fernández-Rodríguez A; Jiménez-Sousa MÁ
Front Immunol; 2022; 13():925558. PubMed ID: 35844615
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients.
Oliveira LB; Mwangi VI; Sartim MA; Delafiori J; Sales GM; de Oliveira AN; Busanello ENB; Val FFAE; Xavier MS; Costa FT; Baía-da-Silva DC; Sampaio VS; de Lacerda MVG; Monteiro WM; Catharino RR; de Melo GC
Front Microbiol; 2022; 13():844283. PubMed ID: 35572676
[TBL] [Abstract][Full Text] [Related]
9. Untargeted saliva metabolomics by liquid chromatography-Mass spectrometry reveals markers of COVID-19 severity.
Frampas CF; Longman K; Spick M; Lewis HM; Costa CDS; Stewart A; Dunn-Walters D; Greener D; Evetts G; Skene DJ; Trivedi D; Pitt A; Hollywood K; Barran P; Bailey MJ
PLoS One; 2022; 17(9):e0274967. PubMed ID: 36137157
[TBL] [Abstract][Full Text] [Related]
10. Leveraging metabolic modeling to identify functional metabolic alterations associated with COVID-19 disease severity.
Dillard LR; Wase N; Ramakrishnan G; Park JJ; Sherman NE; Carpenter R; Young M; Donlan AN; Petri W; Papin JA
Metabolomics; 2022 Jul; 18(7):51. PubMed ID: 35819731
[TBL] [Abstract][Full Text] [Related]
11. An AI-powered patient triage platform for future viral outbreaks using COVID-19 as a disease model.
Charkoftaki G; Aalizadeh R; Santos-Neto A; Tan WY; Davidson EA; Nikolopoulou V; Wang Y; Thompson B; Furnary T; Chen Y; Wunder EA; Coppi A; Schulz W; Iwasaki A; Pierce RW; Cruz CSD; Desir GV; Kaminski N; Farhadian S; Veselkov K; Datta R; Campbell M; Thomaidis NS; Ko AI; ; Thompson DC; Vasiliou V
Hum Genomics; 2023 Aug; 17(1):80. PubMed ID: 37641126
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a machine learning-based in-hospital COVID-19 disease outcome predictor (CODOP): A multicontinental retrospective study.
Klén R; Purohit D; Gómez-Huelgas R; Casas-Rojo JM; Antón-Santos JM; Núñez-Cortés JM; Lumbreras C; Ramos-Rincón JM; García Barrio N; Pedrera-Jiménez M; Lalueza Blanco A; Martin-Escalante MD; Rivas-Ruiz F; Onieva-García MÁ; Young P; Ramirez JI; Titto Omonte EE; Gross Artega R; Canales Beltrán MT; Valdez PR; Pugliese F; Castagna R; Huespe IA; Boietti B; Pollan JA; Funke N; Leiding B; Gómez-Varela D
Elife; 2022 May; 11():. PubMed ID: 35579324
[TBL] [Abstract][Full Text] [Related]
13. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units.
Kugler S; Hahnefeld L; Kloka JA; Ginzel S; Nürenberg-Goloub E; Zinn S; Vehreschild MJ; Zacharowski K; Lindau S; Ullrich E; Burmeister J; Kohlhammer J; Schwäble J; Gurke R; Dorochow E; Bennett A; Dauth S; Campe J; Knape T; Laux V; Kannt A; Köhm M; Geisslinger G; Resch E; Behrens F
Talanta; 2024 Feb; 268(Pt 1):125295. PubMed ID: 37866305
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death.
Gisby J; Clarke CL; Medjeral-Thomas N; Malik TH; Papadaki A; Mortimer PM; Buang NB; Lewis S; Pereira M; Toulza F; Fagnano E; Mawhin MA; Dutton EE; Tapeng L; Richard AC; Kirk PD; Behmoaras J; Sandhu E; McAdoo SP; Prendecki MF; Pickering MC; Botto M; Willicombe M; Thomas DC; Peters JE
Elife; 2021 Mar; 10():. PubMed ID: 33704068
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Robust and Interpretable Early Triaging Support System for Patients Hospitalized With COVID-19: Predictive Algorithm Modeling and Interpretation Study.
Baek S; Jeong YJ; Kim YH; Kim JY; Kim JH; Kim EY; Lim JK; Kim J; Kim Z; Kim K; Chung MJ
J Med Internet Res; 2024 Jan; 26():e52134. PubMed ID: 38206673
[TBL] [Abstract][Full Text] [Related]
16. Saliva metabolomic profile of COVID-19 patients associates with disease severity.
Saheb Sharif-Askari N; Soares NC; Mohamed HA; Saheb Sharif-Askari F; Alsayed HAH; Al-Hroub H; Salameh L; Osman RS; Mahboub B; Hamid Q; Semreen MH; Halwani R
Metabolomics; 2022 Oct; 18(11):81. PubMed ID: 36271948
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide, Phospholipid, and Kynurenine Metabolites Are Robustly Associated with COVID-19 Severity and Time of Plasma Sample Collection in a Prospective Cohort Study.
Chatelaine HAS; Chen Y; Braisted J; Chu SH; Chen Q; Stav M; Begum S; Diray-Arce J; Sanjak J; Huang M; Lasky-Su J; Mathé EA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203516
[TBL] [Abstract][Full Text] [Related]
18. Machine learning prediction for COVID-19 disease severity at hospital admission.
Raman G; Ashraf B; Demir YK; Kershaw CD; Cheruku S; Atis M; Atis A; Atar M; Chen W; Ibrahim I; Bat T; Mete M
BMC Med Inform Decis Mak; 2023 Mar; 23(1):46. PubMed ID: 36882829
[TBL] [Abstract][Full Text] [Related]
19. Untargeted detection of the carbonyl metabolome by chemical derivatization and liquid chromatography-tandem mass spectrometry in precursor ion scan mode: Elucidation of COVID-19 severity biomarkers.
Gomez-Gomez A; Rodríguez-Morató J; Haro N; Marín-Corral J; Masclans JR; Pozo OJ
Anal Chim Acta; 2022 Mar; 1196():339405. PubMed ID: 35151400
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
